Third‐Trimester Cardiovascular Function and Risk of Hypertensive Disorders of Pregnancy
Low CO is associated with preeclampsia risk in women with and without FGR, particularly before 37 weeks. Repeated measurements of third-trimester cardiovascular function might identify women without FGR for monitoring for preeclampsia, but this result needs to be confirmed in other studies.
Authors
- Mads Melbye (ORCID: https://orcid.org/0000-0001-8264-6785)
- Jan Wohlfahrt (ORCID: https://orcid.org/0000-0002-0019-2247)
- Jacob Alexander Lykke (ORCID: https://orcid.org/0000-0002-3698-9792)
- Heather A. Boyd (ORCID: https://orcid.org/0000-0001-6849-9985)
- Frederikke Lihme (ORCID: https://orcid.org/0000-0002-0289-8905)
- Kasper Pihl (ORCID: https://orcid.org/0000-0003-1592-3388)
- Lisa Kristine Grange Persson (ORCID: https://orcid.org/0000-0002-0216-1225)
- Saima Basit
- Annette Thorsen‐Meyer (ORCID: https://orcid.org/0000-0002-1248-4474)
- Maria O. Larsen
- Anita Sylvest Andersen
- Karin H. Lauridsen
Institutions
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- Norwegian University of Science and Technology (NO)
- Herlev Hospital (DK)
- Hvidovre Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Danish Cancer Society (DK)
- Stanford University (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1161/jaha.123.032673
- Citations
- 5
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 2.91
Funders
- Lundbeckfonden
- Novo Nordisk
- Danmarks Frie Forskningsfond
- H. Lundbeck A/S
- National Institutes of Health